Literature DB >> 21683103

The role of the lymphatic system in vaccine trafficking and immune response.

Ivy Pal1, Joshua D Ramsey.   

Abstract

The development and improvement of vaccines has been a significant endeavor on the part of the medical community for more than the last two centuries, and the success of these efforts is obvious when one considers the millions of lives that have been saved. Recent work in the field of vaccines, however, indicates that vaccines may be developed for even more challenging diseases than those previously addressed. It will be important in achieving this feat to account for the physical and chemical processes related to vaccine trafficking, rather than solely relying on our knowledge of the pathogen and our empirical experience. A thorough understanding of the lymphatic system is essential considering the role it plays in antigen trafficking and all immunological activity. This review describes the results of recent work that provides insight into the physiological processes of the lymphatic system and its various components with an emphasis on vaccine antigen trafficking from the administration site to secondary lymphoid tissues and the ensuing immune response. The review also discusses current challenges in designing vaccines and presents modern strategies for designing vaccines to better interface with the lymphatic system.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21683103     DOI: 10.1016/j.addr.2011.05.018

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  15 in total

Review 1.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

2.  Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation.

Authors:  Jun-O Jin; Soyeong Jang; Hyehyun Kim; Junghwan Oh; Sungbo Shim; Minseok Kwak; Peter C W Lee
Journal:  J Vis Exp       Date:  2018-09-16       Impact factor: 1.355

Review 3.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

4.  Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.

Authors:  Sarah N Mueller; Shaomin Tian; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2015-04-08       Impact factor: 4.939

Review 5.  Biomaterials for enhancing anti-cancer immunity.

Authors:  Sandeep T Koshy; David J Mooney
Journal:  Curr Opin Biotechnol       Date:  2016-02-18       Impact factor: 9.740

6.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

Review 7.  Guiding principles in the design of molecular bioconjugates for vaccine applications.

Authors:  Haipeng Liu; Darrell J Irvine
Journal:  Bioconjug Chem       Date:  2015-04-16       Impact factor: 4.774

8.  Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.

Authors:  Dan Cohen; Shir Hazut Krauthammer; Yael C Cohen; Chava Perry; Irit Avivi; Yair Herishanu; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

9.  Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells.

Authors:  Catherine A Fromen; Tojan B Rahhal; Gregory R Robbins; Marc P Kai; Tammy W Shen; J Christopher Luft; Joseph M DeSimone
Journal:  Nanomedicine       Date:  2015-12-01       Impact factor: 5.307

10.  Structure-based programming of lymph-node targeting in molecular vaccines.

Authors:  Haipeng Liu; Kelly D Moynihan; Yiran Zheng; Gregory L Szeto; Adrienne V Li; Bonnie Huang; Debra S Van Egeren; Clara Park; Darrell J Irvine
Journal:  Nature       Date:  2014-02-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.